Literature DB >> 21880505

Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.

C Moermans1, V Heinen, M Nguyen, M Henket, J Sele, M Manise, J L Corhay, R Louis.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease caused by repeated exposure to noxious gases or particles. It is now recognized that the disease also features systemic inflammation. The purpose of our study was to compare airway and systemic inflammation in COPD to that seen in healthy subjects and to relate the inflammation with the disease severity.
METHODS: Ninety-five COPD patients, encompassing the whole severity spectrum of the disease, were recruited from our outpatient clinic and rehabilitation center and compared to 33 healthy subjects. Induced sputum and blood samples were obtained for measurement of inflammatory cell count. Interleukin (IL)-4, IL-6, IL-10, TNF-α and IFN-γ produced by 24h sputum and blood cell cultures were measured.
RESULTS: Compared to healthy subjects, COPD exhibited a prominent airway neutrophilic inflammation associated with a marked IL-10, IL-6 and TNF-α release deficiency that contrasted with a raised IFN-γ production. Neutrophilic inflammation was also prominent at blood level together with raised production of IFN-γ, IL-10 and TNF-α. Furthermore, sputum neutrophilia correlated with disease severity assessed by GOLD stages. Likewise the extent of TNF-α release from blood cells also positively correlated with the disease severity but negatively with that of sputum cell culture. Blood release of TNF-α and IL-6 negatively correlated with body mass index. Altogether, our results showed a significant relationship between cellular marker in blood and sputum but poor relationship between local and systemic release of cytokines.
CONCLUSIONS: COPD is characterized by prominent neutrophilic inflammation and raised IFN-γ production at both bronchial and systemic level. Overproduction of TNF-α at systemic level correlates with disease severity and inversely with body mass index.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880505     DOI: 10.1016/j.cyto.2011.07.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  29 in total

1.  Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study.

Authors:  C Moermans; C Bonnet; E Willems; F Baron; M Nguyen; M Henket; J Sele; J-L Corhay; Y Beguin; R Louis
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 2.  Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

3.  Methodology for Sputum Induction and Laboratory Processing.

Authors:  Julien Guiot; Sophie Demarche; Monique Henket; Virginie Paulus; Sophie Graff; Florence Schleich; Jean-Louis Corhay; Renaud Louis; Catherine Moermans
Journal:  J Vis Exp       Date:  2017-12-17       Impact factor: 1.355

4.  Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.

Authors:  Zibing Liu; Wenye Geng; Chuanwei Jiang; Shujun Zhao; Yong Liu; Ying Zhang; Shucun Qin; Chenxu Li; Xinfang Zhang; Yanhong Si
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-10

5.  Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.

Authors:  Shenjie Tang; Haiyan Cui; Lan Yao; Xiaohui Hao; Yun Shen; Lin Fan; Hua Sun; Zhanjun Zhang; Jian An Huang
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Cytokines in chronic respiratory diseases.

Authors:  Sergei P Atamas; Svetlana P Chapoval; Achsah D Keegan
Journal:  F1000 Biol Rep       Date:  2013-02-01

7.  Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells.

Authors:  Megumi Kudo; Emiko Ogawa; Daisuke Kinose; Akane Haruna; Tamaki Takahashi; Naoya Tanabe; Satoshi Marumo; Yuma Hoshino; Toyohiro Hirai; Hiroaki Sakai; Shigeo Muro; Hiroshi Date; Michiaki Mishima
Journal:  Respir Res       Date:  2012-03-14

8.  Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.

Authors:  Geetanjali Bade; Meraj Alam Khan; Akhilesh Kumar Srivastava; Parul Khare; Krishna Kumar Solaiappan; Randeep Guleria; Nades Palaniyar; Anjana Talwar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-05

9.  Evaluation of Anti-Inflammatory Activity of Citrus latifolia Tanaka Essential Oil and Limonene in Experimental Mouse Models.

Authors:  Raquel Kummer; Fernanda Carolina Fachini-Queiroz; Camila Fernanda Estevão-Silva; Renata Grespan; Expedito Leite Silva; Ciomar Aparecida Bersani-Amado; Roberto Kenji Nakamura Cuman
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-15       Impact factor: 2.629

10.  Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Liang Dong; Jing-Wen Xia; Yi Gong; Zhen Chen; Hai-Hua Yang; Jing Zhang; Jian He; Xiao-Dong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.